Krka faces proceedings over alleged breach of antitrust law

Brussels/Novo Mesto, 1 July - Pharma company Krka will have to defend itself again at the General Court of the EU for alleged breaches of antitrust law in the 2014 perindopril case. Last week, the Court of Justice of the EU upheld the European Commission's appeal and returned the case to the General Court of the EU for reconsideration, Krka said on Monday.